0.015523 0.000000 0.000000 -0.000000 0.013337 0.000000 0.000000 -0.000000 0.012868 0.00000 0.00000 0.00000 Buehrmann, M. Rauh, D. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 4 90.00 90.00 90.00 64.420 74.980 77.710 C16 H12 Cl N3 O2 S 345.803 1-(3-chlorophenyl)-3-methyl-4~{H}-pyrazolo[4,3-c][1,2]benzothiazine 5,5-dioxide non-polymer C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochem.Biophys.Res.Commun. BBRCA9 0146 1090-2104 511 579 586 10.1016/j.bbrc.2019.02.063 30824186 Co-crystal structure determination and cellular evaluation of 1,4-dihydropyrazolo[4,3-c] [1,2] benzothiazine 5,5-dioxide p38 alpha MAPK inhibitors. 2019 90 1 PIXEL 2016-10-20 DECTRIS PILATUS 6M SINGLE WAVELENGTH M x-ray 1 1.00001 1.0 X10SA SLS 1.00001 SYNCHROTRON SLS BEAMLINE X10SA 41343.195 Mitogen-activated protein kinase 14 2.7.11.24 1 man polymer 345.803 1-(3-chlorophenyl)-3-methyl-4~{H}-pyrazolo[4,3-c][1,2]benzothiazine 5,5-dioxide 1 syn non-polymer 18.015 water 7 nat water MAPK 14,Cytokine suppressive anti-inflammatory drug-binding protein,CSBP,MAP kinase MXI2,MAX-interacting protein 2,Mitogen-activated protein kinase p38 alpha,MAP kinase p38 alpha,Stress-activated protein kinase 2a,SAPK2a no no MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE DCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA DPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE DCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA DPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Human sample 1 360 MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A 9606 Homo sapiens 562 Escherichia coli Biological sequence 1 2.27 45.81 VAPOR DIFFUSION, HANGING DROP 100 mM MES pH 5.6-6.2, 20-30 % PEG4000, 50 mM BOG 293.15 citation pdbx_database_proc repository Initial release Data collection Database references 1 0 2019-03-13 1 1 2019-04-03 _citation.journal_abbrev _citation.journal_volume _citation.page_first _citation.page_last N PDBE Y PDBE 2017-07-31 REL REL 9Y5 9Y5 SUBJECT OF INVESTIGATION 9Y5 1-(3-chlorophenyl)-3-methyl-4~{H}-pyrazolo[4,3-c][1,2]benzothiazine 5,5-dioxide HOH water DRG 1 2 9Y5 9Y5 401 A HOH 1 3 HOH HOH 501 A HOH 3 3 HOH HOH 502 A HOH 4 3 HOH HOH 503 A HOH 7 3 HOH HOH 504 A HOH 2 3 HOH HOH 505 A HOH 5 3 HOH HOH 506 A HOH 6 3 HOH HOH 507 A n 1 1 A n 2 2 A n 3 3 A n 4 4 A ARG 5 n 5 ARG 5 A PRO 6 n 6 PRO 6 A THR 7 n 7 THR 7 A PHE 8 n 8 PHE 8 A TYR 9 n 9 TYR 9 A ARG 10 n 10 ARG 10 A GLN 11 n 11 GLN 11 A GLU 12 n 12 GLU 12 A LEU 13 n 13 LEU 13 A ASN 14 n 14 ASN 14 A LYS 15 n 15 LYS 15 A THR 16 n 16 THR 16 A ILE 17 n 17 ILE 17 A TRP 18 n 18 TRP 18 A GLU 19 n 19 GLU 19 A VAL 20 n 20 VAL 20 A PRO 21 n 21 PRO 21 A GLU 22 n 22 GLU 22 A ARG 23 n 23 ARG 23 A TYR 24 n 24 TYR 24 A GLN 25 n 25 GLN 25 A ASN 26 n 26 ASN 26 A LEU 27 n 27 LEU 27 A SER 28 n 28 SER 28 A PRO 29 n 29 PRO 29 A VAL 30 n 30 VAL 30 A n 31 31 A n 32 32 A n 33 33 A n 34 34 A TYR 35 n 35 TYR 35 A GLY 36 n 36 GLY 36 A SER 37 n 37 SER 37 A VAL 38 n 38 VAL 38 A CYS 39 n 39 CYS 39 A ALA 40 n 40 ALA 40 A ALA 41 n 41 ALA 41 A PHE 42 n 42 PHE 42 A ASP 43 n 43 ASP 43 A THR 44 n 44 THR 44 A LYS 45 n 45 LYS 45 A THR 46 n 46 THR 46 A GLY 47 n 47 GLY 47 A LEU 48 n 48 LEU 48 A ARG 49 n 49 ARG 49 A VAL 50 n 50 VAL 50 A ALA 51 n 51 ALA 51 A VAL 52 n 52 VAL 52 A LYS 53 n 53 LYS 53 A LYS 54 n 54 LYS 54 A LEU 55 n 55 LEU 55 A SER 56 n 56 SER 56 A ARG 57 n 57 ARG 57 A PRO 58 n 58 PRO 58 A PHE 59 n 59 PHE 59 A GLN 60 n 60 GLN 60 A SER 61 n 61 SER 61 A ILE 62 n 62 ILE 62 A ILE 63 n 63 ILE 63 A HIS 64 n 64 HIS 64 A ALA 65 n 65 ALA 65 A LYS 66 n 66 LYS 66 A ARG 67 n 67 ARG 67 A THR 68 n 68 THR 68 A TYR 69 n 69 TYR 69 A ARG 70 n 70 ARG 70 A GLU 71 n 71 GLU 71 A LEU 72 n 72 LEU 72 A ARG 73 n 73 ARG 73 A LEU 74 n 74 LEU 74 A LEU 75 n 75 LEU 75 A LYS 76 n 76 LYS 76 A HIS 77 n 77 HIS 77 A MET 78 n 78 MET 78 A LYS 79 n 79 LYS 79 A HIS 80 n 80 HIS 80 A GLU 81 n 81 GLU 81 A ASN 82 n 82 ASN 82 A VAL 83 n 83 VAL 83 A ILE 84 n 84 ILE 84 A GLY 85 n 85 GLY 85 A LEU 86 n 86 LEU 86 A LEU 87 n 87 LEU 87 A ASP 88 n 88 ASP 88 A VAL 89 n 89 VAL 89 A PHE 90 n 90 PHE 90 A THR 91 n 91 THR 91 A PRO 92 n 92 PRO 92 A ALA 93 n 93 ALA 93 A ARG 94 n 94 ARG 94 A SER 95 n 95 SER 95 A LEU 96 n 96 LEU 96 A GLU 97 n 97 GLU 97 A GLU 98 n 98 GLU 98 A PHE 99 n 99 PHE 99 A ASN 100 n 100 ASN 100 A ASP 101 n 101 ASP 101 A VAL 102 n 102 VAL 102 A TYR 103 n 103 TYR 103 A LEU 104 n 104 LEU 104 A VAL 105 n 105 VAL 105 A THR 106 n 106 THR 106 A HIS 107 n 107 HIS 107 A LEU 108 n 108 LEU 108 A MET 109 n 109 MET 109 A GLY 110 n 110 GLY 110 A ALA 111 n 111 ALA 111 A ASP 112 n 112 ASP 112 A LEU 113 n 113 LEU 113 A ASN 114 n 114 ASN 114 A ASN 115 n 115 ASN 115 A n 116 116 A n 117 117 A n 118 118 A n 119 119 A n 120 120 A LYS 121 n 121 LYS 121 A LEU 122 n 122 LEU 122 A THR 123 n 123 THR 123 A ASP 124 n 124 ASP 124 A ASP 125 n 125 ASP 125 A HIS 126 n 126 HIS 126 A VAL 127 n 127 VAL 127 A GLN 128 n 128 GLN 128 A PHE 129 n 129 PHE 129 A LEU 130 n 130 LEU 130 A ILE 131 n 131 ILE 131 A TYR 132 n 132 TYR 132 A GLN 133 n 133 GLN 133 A ILE 134 n 134 ILE 134 A LEU 135 n 135 LEU 135 A ARG 136 n 136 ARG 136 A GLY 137 n 137 GLY 137 A LEU 138 n 138 LEU 138 A LYS 139 n 139 LYS 139 A TYR 140 n 140 TYR 140 A ILE 141 n 141 ILE 141 A HIS 142 n 142 HIS 142 A SER 143 n 143 SER 143 A ALA 144 n 144 ALA 144 A ASP 145 n 145 ASP 145 A ILE 146 n 146 ILE 146 A ILE 147 n 147 ILE 147 A HIS 148 n 148 HIS 148 A ARG 149 n 149 ARG 149 A ASP 150 n 150 ASP 150 A LEU 151 n 151 LEU 151 A LYS 152 n 152 LYS 152 A PRO 153 n 153 PRO 153 A SER 154 n 154 SER 154 A ASN 155 n 155 ASN 155 A LEU 156 n 156 LEU 156 A ALA 157 n 157 ALA 157 A VAL 158 n 158 VAL 158 A ASN 159 n 159 ASN 159 A GLU 160 n 160 GLU 160 A ASP 161 n 161 ASP 161 A CYS 162 n 162 CYS 162 A GLU 163 n 163 GLU 163 A LEU 164 n 164 LEU 164 A LYS 165 n 165 LYS 165 A ILE 166 n 166 ILE 166 A LEU 167 n 167 LEU 167 A ASP 168 n 168 ASP 168 A n 169 169 A n 170 170 A n 171 171 A n 172 172 A n 173 173 A n 174 174 A n 175 175 A n 176 176 A n 177 177 A n 178 178 A n 179 179 A n 180 180 A n 181 181 A n 182 182 A n 183 183 A ALA 184 n 184 ALA 184 A THR 185 n 185 THR 185 A ARG 186 n 186 ARG 186 A TRP 187 n 187 TRP 187 A TYR 188 n 188 TYR 188 A ARG 189 n 189 ARG 189 A ALA 190 n 190 ALA 190 A PRO 191 n 191 PRO 191 A GLU 192 n 192 GLU 192 A ILE 193 n 193 ILE 193 A MET 194 n 194 MET 194 A LEU 195 n 195 LEU 195 A ASN 196 n 196 ASN 196 A TRP 197 n 197 TRP 197 A MET 198 n 198 MET 198 A HIS 199 n 199 HIS 199 A TYR 200 n 200 TYR 200 A ASN 201 n 201 ASN 201 A GLN 202 n 202 GLN 202 A THR 203 n 203 THR 203 A VAL 204 n 204 VAL 204 A ASP 205 n 205 ASP 205 A ILE 206 n 206 ILE 206 A TRP 207 n 207 TRP 207 A SER 208 n 208 SER 208 A VAL 209 n 209 VAL 209 A GLY 210 n 210 GLY 210 A CYS 211 n 211 CYS 211 A ILE 212 n 212 ILE 212 A MET 213 n 213 MET 213 A ALA 214 n 214 ALA 214 A GLU 215 n 215 GLU 215 A LEU 216 n 216 LEU 216 A LEU 217 n 217 LEU 217 A THR 218 n 218 THR 218 A GLY 219 n 219 GLY 219 A ARG 220 n 220 ARG 220 A THR 221 n 221 THR 221 A LEU 222 n 222 LEU 222 A PHE 223 n 223 PHE 223 A PRO 224 n 224 PRO 224 A GLY 225 n 225 GLY 225 A THR 226 n 226 THR 226 A ASP 227 n 227 ASP 227 A HIS 228 n 228 HIS 228 A ILE 229 n 229 ILE 229 A ASP 230 n 230 ASP 230 A GLN 231 n 231 GLN 231 A LEU 232 n 232 LEU 232 A LYS 233 n 233 LYS 233 A LEU 234 n 234 LEU 234 A ILE 235 n 235 ILE 235 A LEU 236 n 236 LEU 236 A ARG 237 n 237 ARG 237 A LEU 238 n 238 LEU 238 A VAL 239 n 239 VAL 239 A GLY 240 n 240 GLY 240 A THR 241 n 241 THR 241 A PRO 242 n 242 PRO 242 A GLY 243 n 243 GLY 243 A ALA 244 n 244 ALA 244 A GLU 245 n 245 GLU 245 A LEU 246 n 246 LEU 246 A LEU 247 n 247 LEU 247 A LYS 248 n 248 LYS 248 A LYS 249 n 249 LYS 249 A ILE 250 n 250 ILE 250 A SER 251 n 251 SER 251 A SER 252 n 252 SER 252 A GLU 253 n 253 GLU 253 A SER 254 n 254 SER 254 A ALA 255 n 255 ALA 255 A ARG 256 n 256 ARG 256 A ASN 257 n 257 ASN 257 A TYR 258 n 258 TYR 258 A ILE 259 n 259 ILE 259 A GLN 260 n 260 GLN 260 A SER 261 n 261 SER 261 A LEU 262 n 262 LEU 262 A THR 263 n 263 THR 263 A GLN 264 n 264 GLN 264 A MET 265 n 265 MET 265 A PRO 266 n 266 PRO 266 A LYS 267 n 267 LYS 267 A MET 268 n 268 MET 268 A ASN 269 n 269 ASN 269 A PHE 270 n 270 PHE 270 A ALA 271 n 271 ALA 271 A ASN 272 n 272 ASN 272 A VAL 273 n 273 VAL 273 A PHE 274 n 274 PHE 274 A ILE 275 n 275 ILE 275 A GLY 276 n 276 GLY 276 A ALA 277 n 277 ALA 277 A ASN 278 n 278 ASN 278 A PRO 279 n 279 PRO 279 A LEU 280 n 280 LEU 280 A ALA 281 n 281 ALA 281 A VAL 282 n 282 VAL 282 A ASP 283 n 283 ASP 283 A LEU 284 n 284 LEU 284 A LEU 285 n 285 LEU 285 A GLU 286 n 286 GLU 286 A LYS 287 n 287 LYS 287 A MET 288 n 288 MET 288 A LEU 289 n 289 LEU 289 A VAL 290 n 290 VAL 290 A LEU 291 n 291 LEU 291 A ASP 292 n 292 ASP 292 A SER 293 n 293 SER 293 A ASP 294 n 294 ASP 294 A LYS 295 n 295 LYS 295 A ARG 296 n 296 ARG 296 A ILE 297 n 297 ILE 297 A THR 298 n 298 THR 298 A ALA 299 n 299 ALA 299 A ALA 300 n 300 ALA 300 A GLN 301 n 301 GLN 301 A ALA 302 n 302 ALA 302 A LEU 303 n 303 LEU 303 A ALA 304 n 304 ALA 304 A HIS 305 n 305 HIS 305 A ALA 306 n 306 ALA 306 A TYR 307 n 307 TYR 307 A PHE 308 n 308 PHE 308 A ALA 309 n 309 ALA 309 A GLN 310 n 310 GLN 310 A TYR 311 n 311 TYR 311 A HIS 312 n 312 HIS 312 A ASP 313 n 313 ASP 313 A PRO 314 n 314 PRO 314 A ASP 315 n 315 ASP 315 A ASP 316 n 316 ASP 316 A GLU 317 n 317 GLU 317 A PRO 318 n 318 PRO 318 A VAL 319 n 319 VAL 319 A ALA 320 n 320 ALA 320 A ASP 321 n 321 ASP 321 A PRO 322 n 322 PRO 322 A TYR 323 n 323 TYR 323 A ASP 324 n 324 ASP 324 A GLN 325 n 325 GLN 325 A SER 326 n 326 SER 326 A PHE 327 n 327 PHE 327 A GLU 328 n 328 GLU 328 A SER 329 n 329 SER 329 A ARG 330 n 330 ARG 330 A ASP 331 n 331 ASP 331 A LEU 332 n 332 LEU 332 A LEU 333 n 333 LEU 333 A ILE 334 n 334 ILE 334 A ASP 335 n 335 ASP 335 A GLU 336 n 336 GLU 336 A TRP 337 n 337 TRP 337 A LYS 338 n 338 LYS 338 A SER 339 n 339 SER 339 A LEU 340 n 340 LEU 340 A THR 341 n 341 THR 341 A TYR 342 n 342 TYR 342 A ASP 343 n 343 ASP 343 A GLU 344 n 344 GLU 344 A VAL 345 n 345 VAL 345 A ILE 346 n 346 ILE 346 A SER 347 n 347 SER 347 A PHE 348 n 348 PHE 348 A VAL 349 n 349 VAL 349 A PRO 350 n 350 PRO 350 A PRO 351 n 351 PRO 351 A PRO 352 n 352 PRO 352 A LEU 353 n 353 LEU 353 A n 354 354 A n 355 355 A n 356 356 A n 357 357 A n 358 358 A n 359 359 A n 360 360 A author_and_software_defined_assembly PISA 1 monomeric none 0 0 15850 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N TYR 9 A N TYR 9 A O VAL 20 A O VAL 20 A N LEU 13 A N LEU 13 A O THR 16 A O THR 16 A N SER 28 A N SER 28 A O ALA 40 A O ALA 40 A N CYS 39 A N CYS 39 A O VAL 52 A O VAL 52 A N ALA 51 A N ALA 51 A O THR 106 A O THR 106 A O VAL 105 A O VAL 105 A N ASP 88 A N ASP 88 A N ALA 157 A N ALA 157 A O LYS 165 A O LYS 165 1 A CG ARG 5 A CG ARG 5 1 Y 1 A CD ARG 5 A CD ARG 5 1 Y 1 A NE ARG 5 A NE ARG 5 1 Y 1 A CZ ARG 5 A CZ ARG 5 1 Y 1 A NH1 ARG 5 A NH1 ARG 5 1 Y 1 A NH2 ARG 5 A NH2 ARG 5 1 Y 1 A CG ARG 10 A CG ARG 10 1 Y 1 A CD ARG 10 A CD ARG 10 1 Y 1 A NE ARG 10 A NE ARG 10 1 Y 1 A CZ ARG 10 A CZ ARG 10 1 Y 1 A NH1 ARG 10 A NH1 ARG 10 1 Y 1 A NH2 ARG 10 A NH2 ARG 10 1 Y 1 A CG GLN 11 A CG GLN 11 1 Y 1 A CD GLN 11 A CD GLN 11 1 Y 1 A OE1 GLN 11 A OE1 GLN 11 1 Y 1 A NE2 GLN 11 A NE2 GLN 11 1 Y 1 A CG GLU 12 A CG GLU 12 1 Y 1 A CD GLU 12 A CD GLU 12 1 Y 1 A OE1 GLU 12 A OE1 GLU 12 1 Y 1 A OE2 GLU 12 A OE2 GLU 12 1 Y 1 A CG LEU 13 A CG LEU 13 1 Y 1 A CD1 LEU 13 A CD1 LEU 13 1 Y 1 A CD2 LEU 13 A CD2 LEU 13 1 Y 1 A CG ASN 14 A CG ASN 14 1 Y 1 A OD1 ASN 14 A OD1 ASN 14 1 Y 1 A ND2 ASN 14 A ND2 ASN 14 1 Y 1 A CG LYS 15 A CG LYS 15 1 Y 1 A CD LYS 15 A CD LYS 15 1 Y 1 A CE LYS 15 A CE LYS 15 1 Y 1 A NZ LYS 15 A NZ LYS 15 1 Y 1 A CG GLU 19 A CG GLU 19 1 Y 1 A CD GLU 19 A CD GLU 19 1 Y 1 A OE1 GLU 19 A OE1 GLU 19 1 Y 1 A OE2 GLU 19 A OE2 GLU 19 1 Y 1 A CG GLU 22 A CG GLU 22 1 Y 1 A CD GLU 22 A CD GLU 22 1 Y 1 A OE1 GLU 22 A OE1 GLU 22 1 Y 1 A OE2 GLU 22 A OE2 GLU 22 1 Y 1 A CG TYR 35 A CG TYR 35 1 Y 1 A CD1 TYR 35 A CD1 TYR 35 1 Y 1 A CD2 TYR 35 A CD2 TYR 35 1 Y 1 A CE1 TYR 35 A CE1 TYR 35 1 Y 1 A CE2 TYR 35 A CE2 TYR 35 1 Y 1 A CZ TYR 35 A CZ TYR 35 1 Y 1 A OH TYR 35 A OH TYR 35 1 Y 1 A CG LYS 45 A CG LYS 45 1 Y 1 A CD LYS 45 A CD LYS 45 1 Y 1 A CE LYS 45 A CE LYS 45 1 Y 1 A NZ LYS 45 A NZ LYS 45 1 Y 1 A CG LEU 48 A CG LEU 48 1 Y 1 A CD1 LEU 48 A CD1 LEU 48 1 Y 1 A CD2 LEU 48 A CD2 LEU 48 1 Y 1 A CG ARG 49 A CG ARG 49 1 Y 1 A CD ARG 49 A CD ARG 49 1 Y 1 A NE ARG 49 A NE ARG 49 1 Y 1 A CZ ARG 49 A CZ ARG 49 1 Y 1 A NH1 ARG 49 A NH1 ARG 49 1 Y 1 A NH2 ARG 49 A NH2 ARG 49 1 Y 1 A CE LYS 54 A CE LYS 54 1 Y 1 A NZ LYS 54 A NZ LYS 54 1 Y 1 A CG ARG 57 A CG ARG 57 1 Y 1 A CD ARG 57 A CD ARG 57 1 Y 1 A NE ARG 57 A NE ARG 57 1 Y 1 A CZ ARG 57 A CZ ARG 57 1 Y 1 A NH1 ARG 57 A NH1 ARG 57 1 Y 1 A NH2 ARG 57 A NH2 ARG 57 1 Y 1 A CG ARG 94 A CG ARG 94 1 Y 1 A CD ARG 94 A CD ARG 94 1 Y 1 A NE ARG 94 A NE ARG 94 1 Y 1 A CZ ARG 94 A CZ ARG 94 1 Y 1 A NH1 ARG 94 A NH1 ARG 94 1 Y 1 A NH2 ARG 94 A NH2 ARG 94 1 Y 1 A CG GLU 97 A CG GLU 97 1 Y 1 A CD GLU 97 A CD GLU 97 1 Y 1 A OE1 GLU 97 A OE1 GLU 97 1 Y 1 A OE2 GLU 97 A OE2 GLU 97 1 Y 1 A CG GLU 98 A CG GLU 98 1 Y 1 A CD GLU 98 A CD GLU 98 1 Y 1 A OE1 GLU 98 A OE1 GLU 98 1 Y 1 A OE2 GLU 98 A OE2 GLU 98 1 Y 1 A CG ASP 101 A CG ASP 101 1 Y 1 A OD1 ASP 101 A OD1 ASP 101 1 Y 1 A OD2 ASP 101 A OD2 ASP 101 1 Y 1 A CG LYS 121 A CG LYS 121 1 Y 1 A CD LYS 121 A CD LYS 121 1 Y 1 A CE LYS 121 A CE LYS 121 1 Y 1 A NZ LYS 121 A NZ LYS 121 1 Y 1 A CG ASP 145 A CG ASP 145 1 Y 1 A OD1 ASP 145 A OD1 ASP 145 1 Y 1 A OD2 ASP 145 A OD2 ASP 145 1 Y 1 A CG GLU 160 A CG GLU 160 1 Y 1 A CD GLU 160 A CD GLU 160 1 Y 1 A OE1 GLU 160 A OE1 GLU 160 1 Y 1 A OE2 GLU 160 A OE2 GLU 160 1 Y 1 A CE LYS 165 A CE LYS 165 1 Y 1 A NZ LYS 165 A NZ LYS 165 1 Y 1 A CG ASN 196 A CG ASN 196 1 Y 1 A OD1 ASN 196 A OD1 ASN 196 1 Y 1 A ND2 ASN 196 A ND2 ASN 196 1 Y 1 A CG MET 198 A CG MET 198 1 Y 1 A SD MET 198 A SD MET 198 1 Y 1 A CE MET 198 A CE MET 198 1 Y 1 A CG LYS 233 A CG LYS 233 1 Y 1 A CD LYS 233 A CD LYS 233 1 Y 1 A CE LYS 233 A CE LYS 233 1 Y 1 A NZ LYS 233 A NZ LYS 233 1 Y 1 A CZ ARG 237 A CZ ARG 237 1 Y 1 A NH1 ARG 237 A NH1 ARG 237 1 Y 1 A NH2 ARG 237 A NH2 ARG 237 1 Y 1 A CG GLU 245 A CG GLU 245 1 Y 1 A CD GLU 245 A CD GLU 245 1 Y 1 A OE1 GLU 245 A OE1 GLU 245 1 Y 1 A OE2 GLU 245 A OE2 GLU 245 1 Y 1 A CG GLN 264 A CG GLN 264 1 Y 1 A CD GLN 264 A CD GLN 264 1 Y 1 A OE1 GLN 264 A OE1 GLN 264 1 Y 1 A NE2 GLN 264 A NE2 GLN 264 1 Y 1 A CE LYS 267 A CE LYS 267 1 Y 1 A NZ LYS 267 A NZ LYS 267 1 Y 1 A CG LEU 353 A CG LEU 353 1 Y 1 A CD1 LEU 353 A CD1 LEU 353 1 Y 1 A CD2 LEU 353 A CD2 LEU 353 1 Y 1 A MET 1 A MET 1 1 Y 1 A SER 2 A SER 2 1 Y 1 A GLN 3 A GLN 3 1 Y 1 A GLU 4 A GLU 4 1 Y 1 A GLY 31 A GLY 31 1 Y 1 A SER 32 A SER 32 1 Y 1 A GLY 33 A GLY 33 1 Y 1 A ALA 34 A ALA 34 1 Y 1 A ILE 116 A ILE 116 1 Y 1 A VAL 117 A VAL 117 1 Y 1 A LYS 118 A LYS 118 1 Y 1 A CYS 119 A CYS 119 1 Y 1 A GLN 120 A GLN 120 1 Y 1 A PHE 169 A PHE 169 1 Y 1 A GLY 170 A GLY 170 1 Y 1 A LEU 171 A LEU 171 1 Y 1 A ALA 172 A ALA 172 1 Y 1 A ARG 173 A ARG 173 1 Y 1 A HIS 174 A HIS 174 1 Y 1 A THR 175 A THR 175 1 Y 1 A ASP 176 A ASP 176 1 Y 1 A ASP 177 A ASP 177 1 Y 1 A GLU 178 A GLU 178 1 Y 1 A MET 179 A MET 179 1 Y 1 A THR 180 A THR 180 1 Y 1 A GLY 181 A GLY 181 1 Y 1 A TYR 182 A TYR 182 1 Y 1 A VAL 183 A VAL 183 1 Y 1 A ASP 354 A ASP 354 1 Y 1 A GLN 355 A GLN 355 1 Y 1 A GLU 356 A GLU 356 1 Y 1 A GLU 357 A GLU 357 1 Y 1 A MET 358 A MET 358 1 Y 1 A GLU 359 A GLU 359 1 Y 1 A SER 360 A SER 360 1 Y 1 A LEU 13 178.05 148.96 1 A PRO 29 -54.94 170.19 1 A ARG 149 81.58 -12.11 1 A ASP 150 -147.57 35.87 1 A LEU 289 -89.23 33.08 63.876 3.30 0.00 -0.00 -3.76 0.00 0.46 0.942 0.910 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS 0.27716 0.21500 0.21817 2.50 48.86 672 12754 5.0 99.11 11.366 0.254 RANDOM 1 THROUGHOUT 0.546 0.316 0.80 0.80 1.20 2.50 48.86 7 2547 23 0 2517 0.013 0.019 2602 0.002 0.020 2432 1.545 1.971 3555 0.972 3.001 5557 4.735 5.000 321 34.104 23.981 108 16.716 15.000 404 18.322 15.000 12 0.080 0.200 412 0.007 0.021 2920 0.002 0.020 591 5.041 6.470 1296 5.023 6.467 1295 7.295 9.689 1613 7.293 9.694 1614 5.424 6.763 1306 5.423 6.765 1307 7.925 10.022 1943 12.075 60.600 10899 12.075 60.603 10900 0.361 0.277 2.565 49 931 20 99.49 2.50 50.0 5OMH 12754 0.063 1 26.78 12.6 99.1 2.50 2.56 3.44 0.96 1 13.5 99.5 refinement REFMAC 5.8.0103 data reduction XDS data scaling XSCALE phasing PHASER N Mitogen-activated protein kinase 14 (E.C.2.7.11.24) p38alpha in complex with pyrazolobenzothiazine inhibitor COXH11 1 N N 2 N N 3 N N A SER 61 A SER 61 HELX_P A MET 78 A MET 78 1 AA1 18 A SER 95 A SER 95 HELX_P A PHE 99 A PHE 99 5 AA2 5 A THR 123 A THR 123 HELX_P A SER 143 A SER 143 1 AA3 21 A LYS 152 A LYS 152 HELX_P A SER 154 A SER 154 5 AA4 3 A THR 185 A THR 185 HELX_P A ARG 189 A ARG 189 5 AA5 5 A ALA 190 A ALA 190 HELX_P A LEU 195 A LEU 195 1 AA6 6 A THR 203 A THR 203 HELX_P A GLY 219 A GLY 219 1 AA7 17 A ILE 229 A ILE 229 HELX_P A GLY 240 A GLY 240 1 AA8 12 A GLY 243 A GLY 243 HELX_P A LYS 248 A LYS 248 1 AA9 6 A SER 252 A SER 252 HELX_P A SER 261 A SER 261 1 AB1 10 A ASN 269 A ASN 269 HELX_P A PHE 274 A PHE 274 1 AB2 6 A ASN 278 A ASN 278 HELX_P A LEU 289 A LEU 289 1 AB3 12 A ASP 292 A ASP 292 HELX_P A ARG 296 A ARG 296 5 AB4 5 A THR 298 A THR 298 HELX_P A LEU 303 A LEU 303 1 AB5 6 A ALA 304 A ALA 304 HELX_P A ALA 309 A ALA 309 5 AB6 6 A GLN 325 A GLN 325 HELX_P A ARG 330 A ARG 330 5 AB7 6 A LEU 333 A LEU 333 HELX_P A SER 347 A SER 347 1 AB8 15 TRANSFERASE p38, kinase, inhibitor, pyrazolobenzothiazine, complex, Transferase MK14_HUMAN UNP 1 1 Q16539 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE DCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA DPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1 360 5OMH 1 360 Q16539 A 1 1 360 2 2 5 2 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A PHE 8 A PHE 8 A TYR 9 A TYR 9 A VAL 20 A VAL 20 A PRO 21 A PRO 21 A GLU 12 A GLU 12 A LEU 13 A LEU 13 A THR 16 A THR 16 A ILE 17 A ILE 17 A TYR 24 A TYR 24 A PRO 29 A PRO 29 A SER 37 A SER 37 A ASP 43 A ASP 43 A ARG 49 A ARG 49 A LYS 54 A LYS 54 A TYR 103 A TYR 103 A HIS 107 A HIS 107 A ASP 88 A ASP 88 A PHE 90 A PHE 90 A LEU 156 A LEU 156 A VAL 158 A VAL 158 A LEU 164 A LEU 164 A ILE 166 A ILE 166 binding site for residue 9Y5 A 401 A 9Y5 401 Software 8 A LYS 53 A LYS 53 8 1_555 A GLU 71 A GLU 71 8 1_555 A THR 106 A THR 106 8 1_555 A HIS 107 A HIS 107 8 1_555 A MET 109 A MET 109 8 1_555 A LEU 167 A LEU 167 8 1_555 A ASP 168 A ASP 168 8 1_555 A HOH 507 C HOH 8 1_555 19 P 21 21 21